These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 9311503)
21. Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process. McKenzie JC; Kelley KB; Merisko-Liversidge EM; Kennedy J; Klein RM J Mol Cell Cardiol; 1994 Jun; 26(6):753-67. PubMed ID: 8089855 [TBL] [Abstract][Full Text] [Related]
22. Effect of the calcium antagonist amlodipine on the two phases of hypoxic pulmonary vasoconstriction in rat large and small isolated pulmonary arteries. Woodmansey PA; Zhang F; Channer KS; Morice AH J Cardiovasc Pharmacol; 1995 Feb; 25(2):324-9. PubMed ID: 7752659 [TBL] [Abstract][Full Text] [Related]
23. The ETA antagonist CI-1020 inhibits hypoxic pulmonary vasoconstriction in small isolated rat pulmonary arteries. Jones RD; Morice AH Pulm Pharmacol Ther; 1998; 11(2-3):177-81. PubMed ID: 9918752 [TBL] [Abstract][Full Text] [Related]
24. Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats. Jin H; Chen YF; Yang RH; Jackson RM; Oparil S J Appl Physiol (1985); 1990 Jun; 68(6):2413-8. PubMed ID: 2166736 [TBL] [Abstract][Full Text] [Related]
25. Endothelial control of the pulmonary circulation in normal and chronically hypoxic rats. Barer G; Emery C; Stewart A; Bee D; Howard P J Physiol; 1993 Apr; 463():1-16. PubMed ID: 8246176 [TBL] [Abstract][Full Text] [Related]
26. Vasodilatory action of the calcium antagonist amlodipine on large and resistance pulmonary arteries from normoxic and chronically hypoxic rats. Woodmansey PA; Zhang F; Channer KS; Morice AH Clin Sci (Lond); 1993 Sep; 85(3):361-6. PubMed ID: 8403809 [TBL] [Abstract][Full Text] [Related]
28. Vasopressin lowers pulmonary artery pressure in hypoxic rats by releasing atrial natriuretic peptide. Jin HK; Chen YF; Yang RH; McKenna TM; Jackson RM; Oparil S Am J Med Sci; 1989 Oct; 298(4):227-36. PubMed ID: 2529763 [TBL] [Abstract][Full Text] [Related]
29. Atrial natriuretic peptide in acute hypoxia-induced pulmonary hypertension in rats. Jin H; Yang RH; Chen YF; Jackson RM; Itoh H; Mukoyama M; Nakao K; Imura H; Oparil S J Appl Physiol (1985); 1991 Sep; 71(3):807-14. PubMed ID: 1661719 [TBL] [Abstract][Full Text] [Related]
30. Hypoxic constrictor response in the isolated pulmonary artery from chronically hypoxic rats. Karamsetty VS; MacLean MR; McCulloch KM; Kane KA; Wadsworth RM Respir Physiol; 1996 Aug; 105(1-2):85-93. PubMed ID: 8897654 [TBL] [Abstract][Full Text] [Related]
31. The NADPH oxidase inhibitors iodonium diphenyl and cadmium sulphate inhibit hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries. Jones RD; Thompson JS; Morice AH Physiol Res; 2000; 49(5):587-96. PubMed ID: 11191363 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of hypoxic pulmonary vasoconstriction in isolated rat pulmonary arteries by diphenyleneiodonium (DPI). Thompson JS; Jones RD; Rogers TK; Hancock J; Morice AH Pulm Pharmacol Ther; 1998 Feb; 11(1):71-5. PubMed ID: 9802966 [TBL] [Abstract][Full Text] [Related]
33. Effects of continuous infusion of atrial natriuretic peptide on the pulmonary hypertension induced by chronic hypoxia in rats. Zhao L; Winter RJ; Krausz T; Hughes JM Clin Sci (Lond); 1991 Sep; 81(3):379-85. PubMed ID: 1655340 [TBL] [Abstract][Full Text] [Related]
34. Modulated vasodilator responses to natriuretic peptides in rats exposed to chronic hypoxia. Mitani Y; Maruyama J; Yokochi A; Maruyama K; Yoshimoto T; Naruse M; Sakurai M Eur Respir J; 2000 Feb; 15(2):400-6. PubMed ID: 10706511 [TBL] [Abstract][Full Text] [Related]
35. Effect of levcromakalim on hypoxia-, KCl- and prostaglandin F2 alpha-induced contractions in isolated rat pulmonary artery. Zhang F; Morice AH J Pharmacol Exp Ther; 1994 Oct; 271(1):326-33. PubMed ID: 7965732 [TBL] [Abstract][Full Text] [Related]
36. Riociguat versus sildenafil on hypoxic pulmonary vasoconstriction and ventilation/perfusion matching. Chamorro V; Morales-Cano D; Milara J; Barreira B; Moreno L; Callejo M; Mondejar-Parreño G; Esquivel-Ruiz S; Cortijo J; Cogolludo Á; Barberá JA; Perez-Vizcaino F PLoS One; 2018; 13(1):e0191239. PubMed ID: 29364918 [TBL] [Abstract][Full Text] [Related]
37. Neutral endopeptidase inhibition increases the potency of ANP in isolated rat pulmonary resistance vessels and isolated blood perfused lungs. Thompson JS; Morice AH Pulm Pharmacol; 1995; 8(2-3):143-7. PubMed ID: 8820254 [TBL] [Abstract][Full Text] [Related]